Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression

Phase 3 Terminated 1 enrolled Research Foundation for Mental Hygiene, Inc.

NaSingle-groupOpen-labelTreatment

Summary

This pilot study aims to test the safety, feasibility, and initial efficacy of combined 10 week treatment of prolonged exposure (PE) and Pramipexole in patients with comorbid posttraumatic stress disorder (PTSD) and depression (MDD). Resting state functional connectivity (rsFC) will be assessed at baseline and en of treatment.

Timeline

Start: 2019-02-19
Primary completion: 2019-08-26
Completion: 2019-08-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pramipexole	Unknown	4 mg	—

Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression

Summary

Timeline

Drugs

Indications